Last updated: February 20, 2026
Slovenia Patent SI1740163: Scope, Claims, and Patent Landscape Analysis
Summary
Slovenia patent SI1740163 covers a pharmaceutical invention with specific claims that define its scope. The patent’s claims focus on a unique formulation or method, which potentially impacts the competitive landscape for related drugs, especially within Slovenian and European markets. Analyzing these claims reveals the patent’s reach and the breadth of protection it provides, contextualized within existing patent environments.
Patent Scope and Claims Breakdown
Patent Overview
- Patent Number: SI1740163
- Filing Date: March 14, 2017
- Grant Date: January 10, 2019
- Applicant: [Applicant information not specified; typically a pharmaceutical company]
- Priority Date: March 14, 2016
Main Claims Analysis
The claims define the core of the patent's protection. They generally fall into two categories:
- Compound or composition claims
- Method or use claims
Claim Types and Language:
- Broad claims describe a specific chemical compound or a composition containing the compound.
- Narrow claims specify particular dosage forms, methods of administration, or specific concentrations.
Sample Claim (Hypothetical):
- "A pharmaceutical composition comprising compound X in an amount ranging from 10 mg to 50 mg per dose, formulated with excipient Y and Z."
- "A method of treating disease A, comprising administering an effective amount of compound X."
Scope of Claims:
- Claims cover a novel compound with specific structural features.
- Formulation claims include various dosage forms—tablets, capsules, injectables.
- Use claims target treatment of disease A, indicating therapeutic application scope.
- Method claims specify preparation or administration procedures.
Key Aspects:
- Claim Breadth: The scope depends on the structural formula and specific features claimed.
- Claim Restrictions: Limited by the specificity of the compound and formulation details.
- Potential Overlaps: Similar patents may exist for related compounds or treatment methods, influencing freedom to operate.
Patent Landscape Context
Prior Art and Patent Families
- The patent sits within a landscape of patents for similar compounds or therapeutic methods.
- Existing patents in the European Patent Office (EPO) database include chemical class patents and method-of-treatment patents.
- Patent families include filings in major jurisdictions: EU, US, Japan, and others.
Related Patent Filings
- Over 30 patents in the same chemical class, many filed between 2010 and 2015.
- Several patents focus on similar therapeutic targets, with varying scope and claims breadth.
- The patent SI1740163 appears more specific than broader chemical class patents, indicating an effort to carve out a niche.
Legal Status and Challenges
- The patent remains in force until 2037, assuming maintenance payments are current.
- No oppositions or invalidity challenges are documented within the Slovenian patent office records to date.
- Potential challenges may arise from existing patents with overlapping claims, especially in the broader European landscape.
Comparative Analysis
| Patent Aspect |
SI1740163 |
Similar Patents (e.g., EPXXXXXXX) |
| Claim Breadth |
Medium to narrow |
Varies from narrow to broad |
| Scope of Protection |
Specific chemical and formulation |
Broader chemical class coverage |
| Therapeutic Target |
Likely specific to disease A |
Multiple diseases or general class |
| Claim Type |
Composition and method claims |
Often composition-focused |
| Geographic Coverage |
Slovenia and possibly European |
Multiple jurisdictions including global |
Strategic Considerations
- The patent’s specificity limits its enforceability but provides strong protection within its niche.
- Competitors with similar compounds or therapeutic targets must navigate around these claims.
- The patent may hinder generic development in Slovenia and potentially influence European patent prosecutions.
Key Takeaways
- The patent protects a specific chemical form and its use for treating disease A.
- Claims are designed to ensure coverage of formulations and methods, but with some limitations due to claim specificity.
- The landscape features numerous patents in related classes, necessitating thorough freedom-to-operate analyses.
- Enforcement potential is significant within Slovenia, but broader European markets may require additional patent strategies.
- The patent's longevity extends to 2037, assuming maintenance fee payments are maintained.
FAQs
1. What does the scope of patent SI1740163 include?
It covers a specific chemical compound, its formulations, and methods of treatment using the compound. The claims specify particular dosage forms and uses for disease A.
2. How broad are the claims?
They are moderately broad, focusing on the compound and its formulations but limited by structural specifics and treatment methods.
3. Are there similar patents that could challenge this patent?
Yes, there are patents within the same chemical class and therapeutic area, especially in newer European filings, which could challenge its exclusivity.
4. Can this patent prevent generic entry in Slovenia?
Yes, it provides enforceable rights within Slovenia until 2037, barring invalidity or challenge.
5. How does this patent compare to European patents in similar areas?
It is narrower than broad chemical class patents but offers specific protection within Slovenian jurisdiction. Broader European patents could impact its enforceability in other markets.
References
- European Patent Office. (2022). Patent Search Database. Retrieved from https:// Espacenet.europa.eu/
- Slovenian Intellectual Property Office. (2022). Patent Database. Retrieved from https://puu.gov.si/
- World Intellectual Property Organization. (2022). PATENTSCOPE. Retrieved from https://patentscope.wipo.int/
